Craneware plc
("Craneware" or the "Company")
Proposed Reduction of Capital and Notice of General Meeting
1 August 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that it has today posted a circular to shareholders (the "Circular"), incorporating a Notice of General Meeting (the "General Meeting"), regarding a proposed reduction of capital. The General Meeting will be held at 3 p.m. on 20 August 2025 at the offices of Craneware plc, Tanfield House, 1 Tanfield, Edinburgh, EH3 5DA, UK.
The proposed reduction of capital, if approved, would create distributable reserves that would give the Company further flexibility to deliver shareholder returns over the coming years either in the form of distributions and/or purchases of the Company's own shares.
The reduction of capital process comprises: (i) the proposed cancellation of the entire amount standing to the credit of the Company's share premium account (the "Share Premium Reduction"); and (ii) the proposed capitalisation of the entire amount standing to the credit of the Company's merger reserve by issuing B Ordinary Shares in the capital of the Company and the subsequent cancellation of such B Ordinary Shares (the "Merger Reserve Reduction"). The Share Premium Reduction and the Merger Reserve Reduction together comprise the "Reduction of Capital".
The Reduction of Capital is conditional upon the passing by the Company's shareholders of the resolutions set out in the Notice of General Meeting, as well as confirmation being obtained from the Court of Session, Edinburgh, Scotland (the "Court").
The Reduction of Capital, if approved by shareholders and confirmed by the Court, is expected to create additional distributable reserves of US$ 284,185,184.18. The Reduction of Capital itself will not involve any distribution or repayment of capital, share premium or merger reserve by the Company and will not reduce the underlying net assets of the Company.
The Circular (including the Notice of General Meeting) will shortly be available for viewing on the Company's website at www.thecranewaregroup.com
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
| Publication of the Circular
|
1 August 2025 |
| Latest time and date for receipt of Forms of Proxy
|
3 p.m. on 18 August 2025 |
| General Meeting
|
3 p.m. on 20 August 2025 |
| Expected date of the first Court hearing for initial directions
|
in or around late August 2025 |
| Capital Reduction Record Time |
6.30 p.m. on the Business Day preceding the Court hearing to confirm the Reduction of Capital |
| Expected date of the second Court hearing to confirm the Reduction of Capital
|
in or around October 2025 |
| Effective Date of the Reduction of Capital |
Business Day after the Court order confirming the Reduction of Capital |
Notes: Each of the times and dates, as set out in the Expected Timetable of Principal Events above, is based on current expectations and is subject to change. If any of the above times and/or dates is changed, the revised times and/or dates will be notified to Shareholders by announcement through a regulatory information service. All above references to times are to London times.
For further information, please contact:
| Craneware plc |
+44 (0)131 550 3100 |
| Keith Neilson, CEO |
|
| Craig Preston, CFO |
|
|
|
|
| Alma Strategic Communications (Financial PR) |
+44 (0)20 3405 0205 |
| Caroline Forde, Kinvara Verdon, Sarah Peters |
craneware@ almastrategic.com |
|
|
|
| Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
| Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
|
| Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
| Patrick Robb, Virginia Bull, James Smith |
|
|
|
|
| Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
| Mark Whitmore, Richard Andrews, Patrick Dolaghan |
|
About The Craneware Group
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth.
As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster-that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider.
The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve-today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.